Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study – A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
- Resource Type
- Article
- Source
- Journal of Infection; Jun2023, Vol. 86 Issue 6, p574-583, 10p
- Subject
- Language
- ISSN
- 01634453